Clinical Trials Logo

Clinical Trial Summary

This study aims to provide a comprehensive report on clinicopathologic features, immunohistochemical/biomarker testing and molecular profile of cervical clear cell carcinoma. This study may help researchers learn more about the molecular profile of cervical clear cell carcinoma.


Clinical Trial Description

PRIMARY OBJECTIVE: I. To perform a retrospective clinicopathologic study on patients diagnosed and treated for clear cell carcinoma of the cervix at M D Anderson Cancer Center (MDACC) and to delineate the immunohistochemical and molecular profile of these cases. OUTLINE: Patients' medical records are reviewed retrospectively, and archival tumor tissue analyzed by immunohistochemistry and next generation sequencing. ;


Study Design


NCT number NCT05046080
Study type Observational
Source M.D. Anderson Cancer Center
Contact
Status Recruiting
Phase
Start date August 6, 2021
Completion date September 29, 2026